1
|
Ishkaeva RA, Salakhieva DV, Garifullin R, Alshadidi R, Laikov AV, Yergeshov AA, Kamalov MI, Abdullin TI. A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties. Curr Res Pharmacol Drug Discov 2022; 4:100148. [PMID: 36593927 PMCID: PMC9804109 DOI: 10.1016/j.crphar.2022.100148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Revised: 11/14/2022] [Accepted: 12/14/2022] [Indexed: 12/23/2022] Open
Abstract
We study for the first time whether triphenylphosphonium (TPP) moiety can improve cellular delivery and redox properties of amphipathic cationic peptides based on YRFK/YrFK cell-penetrating and cytoprotective motif. TPP moiety was found to increase reducing activity of both stereoisomeric peptides in solution and on electrode surface in association with TPP-mediated intramolecular interactions. Among TPP-conjugated peptides, newly synthesized TPP3-YrFK featured both increased antioxidant efficacy and proteolytic resistance. TPP-conjugated peptides preferably mitigated endogenic ROS in mitochondria and cytoplasm of model glioblastoma cells with increased oxidative status. This anti-ROS effect was accompanied by mild reversible decrease of reduced glutathione level in the cells with relatively weak change in glutathione redox forms ratio. Such low interference with cell redox status is in accordance with non-cytotoxic nature of the compounds. Intracellular concentrations of label-free peptides were analyzed by LC-MS/MS, which showed substantial TPP-promoted penetration of YrFK motif across cell plasma membrane. However, according to ΔΨm analysis, TPP moiety did not profoundly enhance peptide interaction with mitochondrial inner membrane. Our study clarifies the role of TPP moiety in cellular delivery of amphipathic cationic oligopeptides. The results suggest TPP moiety as a multi-functional modifier for the oligopeptides which is capable of improving cellular pharmacokinetics and antioxidant activity as well as targeting increased ROS levels. The results encourage further investigation of TPP3-YrFK as a peptide antioxidant with multiple benefits.
Collapse
Key Words
- ABTS, 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
- Amphipathic cationic peptides
- CCCP, carbonyl cyanide 3-chlorophenylhydrazone
- CD, circular dichroism
- Cellular pharmacokinetics
- DCFDA, 2′,7′-dichlorofluorescin diacetate
- GSH, reduced glutathione
- HBSS, Hank's balanced salt solution
- Intramolecular interaction
- LC–MS/MS, liquid chromatography tandem mass-spectrometry
- MCB, monochlorobimane
- MRM, multiple reaction monitoring
- ROS targeting
- ROS, reactive oxygen species
- Redox activity
- SPPS, solid-phase peptide synthesis
- TPP, triphenylphosphonium
- Triphenylphosphonium cation
- aa, amino acid
Collapse
Affiliation(s)
- Rezeda A. Ishkaeva
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Diana V. Salakhieva
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Ruslan Garifullin
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia,Department of Aeronautical Engineering, University of Turkish Aeronautical Association, Türkkuşu Kampüsü, 06790, Ankara, Turkey
| | - Raghad Alshadidi
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Alexander V. Laikov
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Abdulla A. Yergeshov
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Marat I. Kamalov
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia
| | - Timur I. Abdullin
- Department of Biochemistry, Biotechnology, Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Volga Region Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia,Corresponding author. Department of Biochemistry, Biotechnology and Pharmacology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya St., 420008, Kazan, Russia.
| |
Collapse
|
2
|
Remya C, Dileep KV, Koti Reddy E, Mantosh K, Lakshmi K, Sarah Jacob R, Sajith AM, Jayadevi Variyar E, Anwar S, Zhang KYJ, Sadasivan C, Omkumar RV. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation. Comput Struct Biotechnol J 2021; 19:4517-4537. [PMID: 34471497 PMCID: PMC8379669 DOI: 10.1016/j.csbj.2021.07.041] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 07/28/2021] [Accepted: 07/29/2021] [Indexed: 12/24/2022] Open
Abstract
The complex and multifactorial nature of neuropsychiatric diseases demands multi-target drugs that can intervene with various sub-pathologies underlying disease progression. Targeting the impairments in cholinergic and glutamatergic neurotransmissions with small molecules has been suggested as one of the potential disease-modifying approaches for Alzheimer’s disease (AD). Tacrine, a potent inhibitor of acetylcholinesterase (AChE) is the first FDA approved drug for the treatment of AD. Tacrine is also a low affinity antagonist of N-methyl-D-aspartate receptor (NMDAR). However, tacrine was withdrawn from its clinical use later due to its hepatotoxicity. With an aim to develop novel high affinity multi-target directed ligands (MTDLs) against AChE and NMDAR, with reduced hepatotoxicity, we performed in silico structure-based modifications on tacrine, chemical synthesis of the derivatives and in vitro validation of their activities. Nineteen such derivatives showed inhibition with IC50 values in the range of 18.53 ± 2.09 – 184.09 ± 19.23 nM against AChE and 0.27 ± 0.05 – 38.84 ± 9.64 μM against NMDAR. Some of the selected compounds also protected rat primary cortical neurons from glutamate induced excitotoxicity. Two of the tacrine derived MTDLs, 201 and 208 exhibited in vivo efficacy in rats by protecting against behavioral impairment induced by administration of the excitotoxic agent, monosodium glutamate. Additionally, several of these synthesized compounds also exhibited promising inhibitory activitiy against butyrylcholinesterase. MTDL-201 was also devoid of hepatotoxicity in vivo. Given the therapeutic potential of MTDLs in disease-modifying therapy, our studies revealed several promising MTDLs among which 201 appears to be a potential candidate for immediate preclinical evaluations.
Collapse
Key Words
- AChE, acetylcholinesterase
- AChEIs, acetylcholinesterase inhibitors
- AChT, acetylthiocholine
- AD, Alzheimer’s disease
- ADME, absorption, distribution, metabolism and excretion
- Acetylcholinesterase
- Alzheimer’s disease
- BBB, blood brain barrier
- Ca2+, calcium
- ChE, Cholinesterases
- DMEM, Dulbecco’s modified Eagle’s medium
- DTNB, 5,5-dithiobis-(2-nitrobenzoic acid)
- ENM, elastic network modeling
- ER, endoplasmic reticulum
- FRET, fluorescence resonance energy transfer
- G6PD, glucose-6-phosphate dehydrogenase
- HBSS, Hank's balanced salt solution
- IP, intraperitoneal
- LBD, Ligand binding domain
- LC-MS, Liquid chromatography-mass spectrometry
- LiCABEDS, Ligand Classifier of Adaptively Boosting Ensemble Decision Stumps
- MAP2, microtubule associated protein 2
- MD, Molecular dynamics
- MTDLs
- MTDLs, multi-target directed ligands
- MWM, Morris water maze
- NBM, neurobasal medium
- NMA, normal mode analysis
- NMDA receptor
- NMDAR, N-methyl-D-aspartate receptor
- Neuroprotection
- OPLS, Optimized potential for liquid simulations
- PBS, phosphate-buffered saline
- PFA, paraformaldehyde
- Polypharmacology
- RMSD, root mean square deviation
- SAR, structure-activity relationships
- SD, standard deviation
- SVM, support vector machine
- Structure-based drug design
- TBI, traumatic brain injury
- TMD, transmembrane domain
- Tacrine
- h-NMDAR, human NMDAR
- hAChE, human AChE
- ppm, parts per million
Collapse
Affiliation(s)
- Chandran Remya
- Department of Biotechnology and Microbiology, Kannur University, Dr. Janaki Ammal Campus, Thalassery, Kerala 670661, India
| | - K V Dileep
- Laboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa 230-0045, Japan.,Laboratory for Computational and Structural Biology, Jubilee Center for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala 680005, India
| | - Eeda Koti Reddy
- Division of Chemistry, Department of Sciences and Humanities, Vignan's Foundation for Sciences, Technology and Research -VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh 522 213, India
| | - Kumar Mantosh
- Molecular Neurobiology Division, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Thiruvananthapuram, Kerala 695014, India
| | - Kesavan Lakshmi
- Molecular Neurobiology Division, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Thiruvananthapuram, Kerala 695014, India
| | - Reena Sarah Jacob
- Molecular Neurobiology Division, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Thiruvananthapuram, Kerala 695014, India
| | - Ayyiliyath M Sajith
- Post Graduate and Research Department of Chemistry, Kasargod Govt. College, Kannur University, Kasaragod, India
| | - E Jayadevi Variyar
- Department of Biotechnology and Microbiology, Kannur University, Dr. Janaki Ammal Campus, Thalassery, Kerala 670661, India
| | - Shaik Anwar
- Division of Chemistry, Department of Sciences and Humanities, Vignan's Foundation for Sciences, Technology and Research -VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh 522 213, India
| | - Kam Y J Zhang
- Laboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa 230-0045, Japan
| | - C Sadasivan
- Department of Biotechnology and Microbiology, Kannur University, Dr. Janaki Ammal Campus, Thalassery, Kerala 670661, India
| | - R V Omkumar
- Molecular Neurobiology Division, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Thiruvananthapuram, Kerala 695014, India
| |
Collapse
|
3
|
Sharma A, Goring A, Staines KA, Emery RJ, Pitsillides AA, Oreffo RO, Mahajan S, Clarkin CE. Raman spectroscopy links differentiating osteoblast matrix signatures to pro-angiogenic potential. Matrix Biol Plus 2020; 5:100018. [PMID: 33543015 PMCID: PMC7852201 DOI: 10.1016/j.mbplus.2019.100018] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 08/21/2019] [Accepted: 10/09/2019] [Indexed: 01/25/2023] Open
Abstract
Mineralization of bone is achieved by the sequential maturation of the immature amorphous calcium phase to mature hydroxyapatite (HA) and is central in the process of bone development and repair. To study normal and dysregulated mineralization in vitro, substrates are often coated with poly-l-lysine (PLL) which facilitates cell attachment. This study has used Raman spectroscopy to investigate the effect of PLL coating on osteoblast (OB) matrix composition during differentiation, with a focus on collagen specific proline and hydroxyproline and precursors of HA. Deconvolution analysis of murine derived long bone OB Raman spectra revealed collagen species were 4.01-fold higher in OBs grown on PLL. Further, an increase of 1.91-fold in immature mineral species (amorphous calcium phosphate) was coupled with a 9.32-fold reduction in mature mineral species (carbonated apatite) on PLL versus controls. These unique low mineral signatures identified in OBs were linked with reduced alkaline phosphatase enzymatic activity, reduced Alizarin Red staining and altered osteogenic gene expression. The promotion of immature mineral species and restriction of mature mineral species of OB grown on PLL were linked to increased cell viability and pro-angiogenic vascular endothelial growth factor (VEGF) production. These results demonstrate the utility of Raman spectroscopy to link distinct matrix signatures with OB maturation and VEGF release. Importantly, Raman spectroscopy could provide a label-free approach to clinically assess the angiogenic potential of bone during fracture repair or degenerative bone loss.
Collapse
Key Words
- ACP, amorphous calcium phosphate
- ALP, tissue non-specific alkaline phosphatase
- CAP, carbonated apatite
- CCEC, collagenase-collagenase-EDTA-collagenase
- ECM, extracellular matrix
- HA, hydroxyapatite
- HBSS, Hank's balanced salt solution
- MV, matrix vesicles
- OB, osteoblast
- OCP, octacalcium phosphate
- Osteoblast mineralization
- PCA, principle component analysis
- PLL, poly-l-lysine
- Poly-l-lysine
- RT-qPCR, reverse transcription-quantiative PCR
- Raman spectroscopy
- VEGF
- VEGF, vascular endothelial growth factor
Collapse
Affiliation(s)
- Aikta Sharma
- School of Biological Sciences, Highfield Campus, University of Southampton, Southampton, SO17 1BJ, United Kingdom of Great Britain and Northern Ireland
| | - Alice Goring
- School of Biological Sciences, Highfield Campus, University of Southampton, Southampton, SO17 1BJ, United Kingdom of Great Britain and Northern Ireland
| | - Katherine A. Staines
- School of Applied Sciences, Sighthill Campus, Edinburgh Napier University, Edinburgh, EH11 4BN, United Kingdom of Great Britain and Northern Ireland
| | - Roger J.H. Emery
- Department of Surgery and Cancer, Faculty of Medicine, St Mary's Campus, Imperial College London, London, W2 1PG, United Kingdom of Great Britain and Northern Ireland
| | - Andrew A. Pitsillides
- Department of Comparative Biomedical Sciences, Royal Veterinary College, London, NW1 0TU, United Kingdom of Great Britain and Northern Ireland
| | - Richard O.C. Oreffo
- Centre for Human Development, Stem Cell and Regeneration, Institute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom of Great Britain and Northern Ireland
| | - Sumeet Mahajan
- School of Chemistry and Institute for Life Sciences, Highfield Campus, University of Southampton, Southampton, SO17 1BJ, United Kingdom of Great Britain and Northern Ireland
| | - Claire E. Clarkin
- School of Biological Sciences, Highfield Campus, University of Southampton, Southampton, SO17 1BJ, United Kingdom of Great Britain and Northern Ireland
| |
Collapse
|
4
|
Valentini X, Deneufbourg P, Paci P, Rugira P, Laurent S, Frau A, Stanicki D, Ris L, Nonclercq D. Morphological alterations induced by the exposure to TiO 2 nanoparticles in primary cortical neuron cultures and in the brain of rats. Toxicol Rep 2018; 5:878-889. [PMID: 30175048 PMCID: PMC6118103 DOI: 10.1016/j.toxrep.2018.08.006] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2018] [Revised: 08/09/2018] [Accepted: 08/12/2018] [Indexed: 12/17/2022] Open
Abstract
Nowadays, nanoparticles (NPs) of titanium dioxide (TiO2) are abundantly produced. TiO2 NPs are present in various food products, in paints, cosmetics, sunscreens and toothpastes. However, the toxicity of TiO2 NPs on the central nervous system has been poorly investigated until now. The aim of this study was to evaluate the toxicity of TiO2 NPs on the central nervous system in vitro and in vivo. In cell cultures derived from embryonic cortical brain of rats, a significant decrease in neuroblasts was observed after 24 to 96 h of incubation with TiO2 NPs (5 to 20 μg/ml). This phenomenon resulted from an inhibition of neuroblast proliferation and a concomitant increase in apoptosis. In the same time, a gliosis, characterized by an increase in proliferation of astrocytes and the hypertrophy of microglial cells, occurred. The phagocytosis of TiO2 NPs by microgliocytes was also observed. In vivo, after intraperitoneal injection, the TiO2 NPs reached the brain through the blood brain barrier and the nanoparticles promoted various histological injuries such as cellular lysis, neuronal apoptosis, and inflammation. A reduction of astrocyte population was observed in some brain area such as plexiform zone, cerebellum and subependymal area. An oxidative stress was also detected by immunohistochemistry in neurons of hippocampus, cerebellum and in subependymal area. In conclusion, our study demonstrated clearly the toxic impact of TiO2 NPs on rat brain and neuronal cells and pointed about not yet referenced toxicity impacts of TiO2 such as the reduction of neuroblast proliferation both in vitro and in vivo.
Collapse
Key Words
- 4-HNE, 4-hydroxynonenal
- ATP, adenosine triphosphate
- BBB, blood-brain barrier
- Brain
- BrdU, 5-Bromo-2′-deoxyuridine
- CNS, central nervous system
- Cell culture
- DLS, dynamic light scattering
- FBS, fetal bovine serum
- GFAP, glial fibrillary acidic protein
- HBSS, Hank's balanced salt solution
- IL-10, interleukin-10
- IL-1β, interleukin-1β
- IP, intraperitoneal
- MAP2, microtubule-associated protein 2
- MDA, malondialdehyde
- NMDA, N-methyl-D-aspartate
- NO, nitric oxide
- NOS, nitric oxide synthase
- NPs, nanoparticles
- Nanoparticles
- Oxidative stress
- Proliferation
- ROS, reactive oxygen species
- SEM, standard error of the mean
- TNF-α, tumor necrosis factor-α
Collapse
Affiliation(s)
- Xavier Valentini
- Laboratory of Histology, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Pauline Deneufbourg
- Laboratory of Neurosciences, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Paula Paci
- Laboratory of Neurosciences, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Pascaline Rugira
- Laboratory of Histology, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Sophie Laurent
- Laboratory of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Institute for Health Sciences and Technology, Institute of Biosciences, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
- Center for Microscopy and Molecular Imaging (CMMI), B-6041 Gosselies, Belgium
| | - Annica Frau
- Laboratory of Histology, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Dimitri Stanicki
- Laboratory of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Institute for Health Sciences and Technology, Institute of Biosciences, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Laurence Ris
- Laboratory of Neurosciences, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
| | - Denis Nonclercq
- Laboratory of Histology, University of Mons, Institute for Health Sciences and Technology, Faculty of Medicine and Pharmacy, 23, Place du Parc, B-7000 Mons, Belgium
- Corresponding author at: 6, Avenue du Champ de Mars, Mons, 7000, Belgium.
| |
Collapse
|
5
|
Means AL, Freeman TJ, Zhu J, Woodbury LG, Marincola-Smith P, Wu C, Meyer AR, Weaver CJ, Padmanabhan C, An H, Zi J, Wessinger BC, Chaturvedi R, Brown TD, Deane NG, Coffey RJ, Wilson KT, Smith JJ, Sawyers CL, Goldenring JR, Novitskiy SV, Washington MK, Shi C, Beauchamp RD. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 2018; 6:257-276. [PMID: 30109253 PMCID: PMC6083016 DOI: 10.1016/j.jcmgh.2018.05.006] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Accepted: 05/18/2018] [Indexed: 02/08/2023]
Abstract
Background & Aims Chronic inflammation is a predisposing condition for colorectal cancer. Many studies to date have focused on proinflammatory signaling pathways in the colon. Understanding the mechanisms that suppress inflammation, particularly in epithelial cells, is critical for developing therapeutic interventions. Here, we explored the roles of transforming growth factor β (TGFβ) family signaling through SMAD4 in colonic epithelial cells. Methods The Smad4 gene was deleted specifically in adult murine intestinal epithelium. Colitis was induced by 3 rounds of dextran sodium sulfate in drinking water, after which mice were observed for up to 3 months. Nontransformed mouse colonocyte cell lines and colonoid cultures and human colorectal cancer cell lines were analyzed for responses to TGFβ1 and bone morphogenetic protein 2. Results Dextran sodium sulfate treatment was sufficient to drive carcinogenesis in mice lacking colonic Smad4 expression, with resulting tumors bearing striking resemblance to human colitis-associated carcinoma. Loss of SMAD4 protein was observed in 48% of human colitis-associated carcinoma samples as compared with 19% of sporadic colorectal carcinomas. Loss of Smad4 increased the expression of inflammatory mediators within nontransformed mouse colon epithelial cells in vivo. In vitro analysis of mouse and human colonic epithelial cell lines and organoids indicated that much of this regulation was cell autonomous. Furthermore, TGFβ signaling inhibited the epithelial inflammatory response to proinflammatory cytokines. Conclusions TGFβ suppresses the expression of proinflammatory genes in the colon epithelium, and loss of its downstream mediator, SMAD4, is sufficient to initiate inflammation-driven colon cancer. Transcript profiling: GSE100082.
Collapse
Key Words
- AOM, azoxymethane
- APC, adenomatous polyposis coli
- BMP, bone morphogenetic protein
- CAC, colitis-associated carcinoma
- CCL20, Chemokine (C-C motif) ligand 20
- CRC, colorectal cancer
- CRISPR/Cas9, Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9
- Colitis-Associated Carcinoma
- DMEM, Dulbecco's modified Eagle medium
- DSS, dextran sodium sulfate
- FBS, fetal bovine serum
- FDR, false discovery rate
- GFP, green fluorescent protein
- HBSS, Hank's balanced salt solution
- IBD, inflammatory bowel disease
- IL, interleukin
- IMCS4fl/fl, immortalized mouse colonoctye cell line with loxP-flanked Smad4 alleles
- IMCS4null, immortalized mouse colonocyte cell line with deletion of the Smad4 alleles
- LPS, lipopolysaccharide
- PBS, phosphate-buffered saline
- PE, phycoerythrin
- R-SMAD, Receptor-SMAD
- SFG, retroviral vector
- STAT3, signal transducer and activator of transcription 3
- TGFβ
- TGFβ, transforming growth factor β
- TNF, tumor necrosis factor
- Tumor Necrosis Factor
- UC, ulcerative colitis
- WNT, wingless-type mouse mammary tumor virus integration site
- YAMC, young adult mouse colon epithelial cells
- mRNA, messenger RNA
- sgRNA, single-guide RNA
Collapse
Affiliation(s)
- Anna L. Means
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Tanner J. Freeman
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Jing Zhu
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Luke G. Woodbury
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | | | - Chao Wu
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Anne R. Meyer
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Connie J. Weaver
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | | | - Hanbing An
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Jinghuan Zi
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Bronson C. Wessinger
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Rupesh Chaturvedi
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Tasia D. Brown
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Natasha G. Deane
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Robert J. Coffey
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
- Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
| | - Keith T. Wilson
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
- Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
| | - J. Joshua Smith
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Charles L. Sawyers
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
| | - James R. Goldenring
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
- Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
| | - Sergey V. Novitskiy
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
| | - M. Kay Washington
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Chanjuan Shi
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
| | - R. Daniel Beauchamp
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee
| |
Collapse
|
6
|
Ye W, Takabayashi H, Yang Y, Mao M, Hibdon ES, Samuelson LC, Eaton KA, Todisco A. Regulation of Gastric Lgr5+ve Cell Homeostasis by Bone Morphogenetic Protein (BMP) Signaling and Inflammatory Stimuli. Cell Mol Gastroenterol Hepatol 2018; 5:523-538. [PMID: 29930977 PMCID: PMC6009760 DOI: 10.1016/j.jcmgh.2018.01.007] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2017] [Accepted: 01/09/2018] [Indexed: 12/15/2022]
Abstract
BACKGROUND & AIMS Gastric Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) cells exert important functions during injury and homeostasis. Bone morphogenetic protein (BMP) signaling regulates gastric inflammation and epithelial homeostasis. We investigated if BMP signaling controls the fate of Lgr5+ve cells during inflammation. METHODS The H+/K+-adenosine triphosphatase β-subunit promoter was used to express the BMP inhibitor noggin (Nog) in the stomach (H+/K+-Nog mice). Inhibition of BMP signaling in Lgr5 cells was achieved by crossing Lgr5-EGFP-ires-CreERT2 (Lgr5-Cre) mice to mice with floxed alleles of BMP receptor 1A (Lgr5-Cre;Bmpr1aflox/flox mice). Lgr5/GFP+ve cells were isolated using flow cytometry. Lineage tracing studies were conducted by crossing Lgr5-Cre mice to mice that express Nog and tdTomato (Lgr5-Cre;H+/K+-Nog;Rosa26-tdTom). Infection with Helicobacter felis was used to induce inflammation. Morphology of the mucosa was analyzed by H&E staining. Distribution of H+/K+-adenosine triphosphatase-, IF-, Ki67-, CD44-, CD44v9-, and bromodeoxyuridine-positive cells was analyzed by immunostaining. Expression of neck and pit cell mucins was determined by staining with the lectins Griffonia (Bandeiraea) simplicifolia lectin II and Ulex europaeus agglutinin 1, respectively. Id1, Bmpr1a, Lgr5, c-Myc, and Cd44 messenger RNAs were measured by quantitative reverse-transcription polymerase chain reaction. RESULTS Lgr5-Cre;Bmpr1aflox/flox mice showed diminished expression of Bmpr1a in Lgr5/GFP+ve cells. Infection of Lgr5-Cre;Bmpr1aflox/flox mice with H felis led to enhanced inflammation, increased cell proliferation, parietal cell loss, and to the development of metaplasia and dysplasia. Infected Lgr5-Cre;H+/K+-Nog;Rosa26-tdTom mice, but not control mice, showed the presence of tomato+ve glands lining the lesser curvature that stained positively with Griffonia (Bandeiraea) simplicifolia lectin II and Ulex europaeus agglutinin 1, and with anti-IF, -CD44, -CD44v9, and -bromodeoxyuridine antibodies. CONCLUSIONS Inflammation and inhibition of BMP signaling activate Lgr5+ve cells, which give rise to metaplastic, dysplastic, proliferating lineages that express markers of mucus neck and zymogenic cell differentiation.
Collapse
Key Words
- ATPase, adenosine triphosphatase
- BMP, bone morphogenetic protein
- BrdU, bromodeoxyuridine
- Chief Cells
- Differentiation
- Dysplasia
- EGFP, enhanced green fluorescent protein
- ERK, extracellular signal–regulated kinase
- GFP, green fluorescent protein
- GSII, Griffonia (Bandeiraea) simplicifolia lectin II
- H/K-nog, H/K-noggin
- HBSS, Hank's balanced salt solution
- IF, intrinsic factor
- Metaplasia
- QRT-PCR, quantitative reverse-transcription polymerase chain reaction
- SPEM, spasmolytic polypeptide expressing metaplasia
- TFF2, Trefoil factor 2
- mRNA, messenger RNA
Collapse
Affiliation(s)
- Wei Ye
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan,Department of Gastroenterology, Hangzhou Chinese Medicine Hospital, Hangzhou, Zhejiang, China
| | - Hidehiko Takabayashi
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
| | - Yitian Yang
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan,Department of Gastroenterology, Hangzhou Chinese Medicine Hospital, Hangzhou, Zhejiang, China
| | - Maria Mao
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
| | - Elise S. Hibdon
- Department of Molecular and Integrative Physiology, University of Michigan Medical Center, Ann Arbor, Michigan
| | - Linda C. Samuelson
- Department of Molecular and Integrative Physiology, University of Michigan Medical Center, Ann Arbor, Michigan
| | - Kathryn A. Eaton
- Department of Microbiology and Immunology, University of Michigan Medical Center, Ann Arbor, Michigan
| | - Andrea Todisco
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan,Correspondence Address correspondence to: Andrea Todisco, MD, 6520 Medical Science Research Building I, Ann Arbor, Michigan 48109-0682. fax: (734) 763-2535.
| |
Collapse
|
7
|
Zhang SF, Wang XY, Fu ZQ, Peng QH, Zhang JY, Ye F, Fu YF, Zhou CY, Lu WG, Cheng XD, Xie X. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer. Autophagy 2016; 11:225-38. [PMID: 25607466 DOI: 10.1080/15548627.2014.998931] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Paclitaxel is recommended as a first-line chemotherapeutic agent against ovarian cancer, but drug resistance becomes a major limitation of its success clinically. The key molecule or mechanism associated with paclitaxel resistance in ovarian cancer still remains unclear. Here, we showed that TXNDC17 screened from 356 differentially expressed proteins by LC-MS/MS label-free quantitative proteomics was more highly expressed in paclitaxel-resistant ovarian cancer cells and tissues, and the high expression of TXNDC17 was associated with poorer prognostic factors and exhibited shortened survival in 157 ovarian cancer patients. Moreover, paclitaxel exposure induced upregulation of TXNDC17 and BECN1 expression, increase of autophagosome formation, and autophagic flux that conferred cytoprotection for ovarian cancer cells from paclitaxel. TXNDC17 inhibition by siRNA or enforced overexpression by a pcDNA3.1(+)-TXNDC17 plasmid correspondingly decreased or increased the autophagy response and paclitaxel resistance. Additionally, the downregulation of BECN1 by siRNA attenuated the activation of autophagy and cytoprotection from paclitaxel induced by TXNDC17 overexpression in ovarian cancer cells. Thus, our findings suggest that TXNDC17, through participation of BECN1, induces autophagy and consequently results in paclitaxel resistance in ovarian cancer. TXNDC17 may be a potential predictor or target in ovarian cancer therapeutics.
Collapse
Key Words
- 95% CI, 95% confidence interval
- ALDOC, aldolase C, fructose-bisphosphate
- ATG5, autophagy-related 5
- BECN1
- BECN1, Beclin 1, autophagy-related
- BafA1, bafilomycin A1
- CNN3, calponin 3, acidic
- DAPI, 4', 6-diamidino-2-phenylindole
- FLNA, filamin A, α
- GO, gene ontology
- GenMAPP, gene microarray pathway profiler
- HBSS, Hank's balanced salt solution
- HR, hazard ratio
- KEGG, Kyoto encyclopedia of genes and genome
- LC-MS/MS, liquid chromatography-mass spectrometry/ mass spectrometry
- MAP1LC3B/LC3B, microtubule-associated protein 1 light chain 3 β
- OS, overall survival
- PFS, progression-free survival
- PGAM1, phosphoglycerate mutase 1 (brain)
- SQSTM1, sequestosome 1
- TNF, tumor necrosis factor
- TXN, thioredoxin
- TXNDC17
- TXNDC17, thioredoxin domain containing 17
- UTP23, small subunit (SSU) processome component, homolog (yeast)
- autophagy
- ovarian cancer
- paclitaxel resistance
- siRNA, short interfering RNA
Collapse
Affiliation(s)
- Song-Fa Zhang
- a Women's Reproductive Health Laboratory of Zhejiang Province; Women's Hospital; School of Medicine ; Zhejiang University ; Hangzhou , China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Soroosh A, Albeiroti S, West GA, Willard B, Fiocchi C, de la Motte CA. Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments. Cell Mol Gastroenterol Hepatol 2016; 2:358-368.e4. [PMID: 27981209 PMCID: PMC5042354 DOI: 10.1016/j.jcmgh.2015.12.007] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 12/22/2015] [Indexed: 12/11/2022]
Abstract
BACKGROUND & AIMS Crohn's Disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Fibrosis, a serious complication of CD, occurs when activated intestinal fibroblasts deposit excessive amounts of extracellular matrix (ECM) in affected areas. A major component of the ECM is high-molecular-weight hyaluronan (HA) that, when depolymerized to low-molecular-weight fragments, becomes proinflammatory and profibrotic. Mechanisms for HA degradation are incompletely understood, but the novel protein KIAA1199 recently was discovered to degrade HA. We hypothesized that KIAA1199 protein is increased in CD colon fibroblasts and generates HA fragments that foster inflammation and fibrosis. METHODS Fibroblasts were isolated from explants of surgically resected colon tissue from CD and non-inflammatory bowel disease control (ND) patients. Protein levels and tissue distribution of KIAA1199 were assessed by immunoblot and immunostaining, and functional HA degradation was measured biochemically. RESULTS Increased levels of KIAA1199 protein were produced and deposited in the ECM by cultured CD fibroblasts compared with controls. Treatment of fibroblasts with the proinflammatory cytokine interleukin (IL) 6 increased deposition of KIAA1199 in the ECM. CD fibroblasts also produce significantly higher levels of IL6 compared with controls, and antibody blockade of IL6 receptors in CD colon fibroblasts decreased the level of KIAA1199 protein in the ECM. Colon fibroblasts degrade HA, however, small interfering RNA silencing of KIAA1199 abrogated that ability. CONCLUSIONS CD fibroblasts produce increased levels of KIAA1199 primarily through an IL6-driven autocrine mechanism. This leads to excessive degradation of HA and the generation of proinflammatory HA fragments, which contributes to maintenance of gut inflammation and fibrosis.
Collapse
Key Words
- CD, Crohn’s disease
- Crohn’s Disease
- DAMP, damage-associated molecular pattern
- ECM, extracellular matrix
- FBS, fetal bovine serum
- Fibrosis
- HA, hyaluronan
- HBSS, Hank's balanced salt solution
- HIF, human intestinal fibroblasts
- HYAL, hyaluronidase
- Hyaluronan
- IBD, inflammatory bowel disease
- IL, interleukin
- IL6R, interleukin 6 receptor
- KIAA1199
- LC-MS, liquid chromatography–mass spectrometry
- ND, non–inflammatory bowel disease control
- NF-κB, nuclear factor-κB
- PAGE, polyacrylamide gel electrophoresis
- PBST, phosphate-buffered saline with 0.1% Tween-20
- SDS, sodium dodecyl sulfate
- TGF, transforming growth factor
- TLR, Toll-like receptor
- TNF, tumor necrosis factor
- siRNA, small interfering RNA
Collapse
Affiliation(s)
- Artin Soroosh
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
| | - Sami Albeiroti
- Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California
| | - Gail A. West
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
| | - Belinda Willard
- Research Core Services, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
| | - Claudio Fiocchi
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
| | - Carol A. de la Motte
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio,Correspondence Address correspondence to: Carol A. de la Motte, PhD, Lerner Research Institute of the Cleveland Clinic, NC22, 9500 Euclid Avenue, Cleveland, Ohio 44195. fax: (216) 636-0104.Lerner Research Institute of the Cleveland ClinicNC22, 9500 Euclid AvenueClevelandOhio 44195
| |
Collapse
|
9
|
Mimouna S, Bazin M, Mograbi B, Darfeuille-Michaud A, Brest P, Hofman P, Vouret-Craviari V. HIF1A regulates xenophagic degradation of adherent and invasive Escherichia coli (AIEC). Autophagy 2015; 10:2333-45. [PMID: 25484075 PMCID: PMC4502747 DOI: 10.4161/15548627.2014.984275] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
The hypoxia inducible transcription factor HIF1 activates autophagy, a general catabolic pathway involved in the maintenance of cellular homeostasis. Dysfunction in both autophagy and HIF1 has been implicated in an increasing number of human diseases, including inflammatory bowel disease (IBD), such as Crohn disease (CD). Adherent invasive E. coli (AIEC) colonize ileal mucosa of CD patients and strongly promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses. Here, we aim to characterize the contribution of HIF1 in xenophagy, a specialized form of autophagy involved in the degradation of intracellular bacteria. Our results showed that endogenous HIF1A knockdown increased AIEC survival in intestinal epithelial cells. We demonstrate that the increase in survival rate correlates with a dramatic impairment of the autophagic flux at the autolysosomal maturation step. Furthermore, we show that AIEC remained within single-membrane LC3-II-positive vesicles and that they were unable to induce the phosphorylation of ULK1. These results suggested that, in the absence of HIF1A, AIEC were found within LC3-associated phagosomes. Using blocking antibodies against TLR5 and CEACAM6, the 2 well-known AIEC-bound receptors, we showed that downstream receptor signaling was necessary to mediate ULK1 phosphorylation. Finally, we provide evidence that HIF1 mediates CEACAM6 expression and that CEACAM6 is necessary to recruit ULK1 in a bacteria-containing signaling hub. Collectively, these results identify a new function for HIF1 in AIEC-dedicated xenophagy, and suggest that coactivation of autophagy and HIF1A expression may be a potential new therapy to resolve AIEC infection in CD patients.
Collapse
Key Words
- AIEC, adherent invasive E. coli
- AMPK, AMP-activated protein kinase
- ATG16L1, autophagy-related 16-like 1
- ATG5, autophagy-related 5
- BECN1, Beclin 1, autophagy-related
- BNIP3L, BCL2/adenovirus E1B 19kDa interacting protein 3-like
- CD, Crohn disease
- CEACAM6, carcinoembryonic antigen-related cell adhesion molecule 6 (nonspecific cross reacting antigen)
- CRTC1/TORC1, CREB regulated transcription coactivator 1
- Crohn disease
- EEA1, early endosome antigen 1
- GFP, green fluorescent protein
- HBSS, Hank's balanced salt solution
- HIF1A, hypoxia inducible factor 1, α subunit (basic helix-loop-helix transcription factor)
- IBD, inflammatory bowel disease
- IRGM, immunity-related GTPase family, M
- LAP
- LAP, LC3-associated phagocytosis
- MAP1LC3-II (LC3-II), microtubule-associated protein 1 light chain 3-II
- MOI, multiplicity of infection
- SQSTM1/p62 (SQSTM1), sequestosome 1
- TEM, transmission electron microscopy
- TLR5, toll-like receptor 5
- ULK1, unc-51 like autophagy activating kinase 1
- VAV2, vav 2 guanine nucleotide exchange factor
- autophagy
- bacteria
- hypoxia inducible factor
Collapse
Affiliation(s)
- Sanda Mimouna
- a Institute for Research on Cancer and Aging; IRCAN U1081 UMR CNRS/UNS 7284 ; Nice , France
| | | | | | | | | | | | | |
Collapse
|
10
|
Malhotra R, Warne JP, Salas E, Xu AW, Debnath J. Loss of Atg12, but not Atg5, in pro-opiomelanocortin neurons exacerbates diet-induced obesity. Autophagy 2015; 11:145-54. [PMID: 25585051 DOI: 10.1080/15548627.2014.998917] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
The autophagy-related proteins ATG12 and ATG5 form a covalent complex essential for autophagy. Here, we demonstrate that ATG12 has distinct functions from ATG5 in pro-opiomelanocortin (POMC)-expressing neurons. Upon high-fat diet (HFD) consumption, mice lacking Atg12 in POMC-positive neurons exhibit accelerated weight gain, adiposity, and glucose intolerance, which is associated with increased food intake, reduced ambulation, and decreased LEP/leptin sensitivity. Importantly, although genetic deletion of either Atg12 or Atg5 renders POMC neurons autophagy-deficient, mice lacking Atg5 in POMC neurons do not exhibit these phenotypes. Hence, we propose nonautophagic functions for ATG12 in POMC neurons that counteract excessive weight gain in response to HFD consumption.
Collapse
Key Words
- AGRP, agouti-related peptide
- ATG12
- ATG5
- BAC, bacterial artificial chromosome
- BMD, bone mineral density
- BafA, bafilomycin A1
- CLAMS, Comprehensive Lab Animal Monitoring System
- DEXA, dual energy X-ray absorptiometry
- HBSS, Hank's balanced salt solution
- HFD, high-fat diet
- LC3-II, phosphatidylethanolamine conjugated isoform of microtubule-associated protein 1 light chain 3
- LEP, leptin
- MAP1LC3, microtubule-associated protein 1 light chain 3
- MEFs, mouse embryonic fibroblasts
- NBR1, neighbor of BRCA1 gene 1
- NPY, neuropeptide Y
- PBS, phosphate-buffered saline
- PE, phosphatidylethanolamine
- POMC
- POMC/ACTH, pro-opiomelanocortin-α (in mice), proopiomelanocortin (in humans)
- SQSTM1/p62, sequestosome 1
- SV40Tag, simian virus 40 T antigen
- UBL, ubiquitin-like molecule
- autophagy
- diet-induced obesity
- hypothalamus
- leptin
- pSTAT3, phosphorylated form of signal transducer and activator of transcription 3 (acute-phase response factor)
Collapse
Affiliation(s)
- Ritu Malhotra
- a Department of Pathology and Helen Diller Family Comprehensive Cancer Center ; University of California ; San Francisco , CA USA
| | | | | | | | | |
Collapse
|
11
|
Giegerich AK, Kuchler L, Sha LK, Knape T, Heide H, Wittig I, Behrends C, Brüne B, von Knethen A. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression. Autophagy 2014; 10:1937-52. [PMID: 25483963 DOI: 10.4161/auto.32178] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Lipopolysaccharide (LPS)-induced activation of TLR4 (toll-like receptor 4) is followed by a subsequent overwhelming inflammatory response, a hallmark of the first phase of sepsis. Therefore, counteracting excessive innate immunity by autophagy is important to contribute to the termination of inflammation. However, the exact molecular details of this interplay are only poorly understood. Here, we show that PELI3/Pellino3 (pellino E3 ubiquitin protein ligase family member 3), which is an E3 ubiquitin ligase and scaffold protein in TLR4-signaling, is impacted by autophagy in macrophages (MΦ) after LPS stimulation. We noticed an attenuated mRNA expression of proinflammatory Il1b (interleukin 1, β) in Peli3 knockdown murine MΦ in response to LPS treatment. The autophagy adaptor protein SQSTM1/p62 (sequestosome 1) emerged as a potential PELI3 binding partner in TLR4-signaling. siRNA targeting Sqstm1 and Atg7 (autophagy related 7), pharmacological inhibition of autophagy by wortmannin as well as blocking the lysosomal vacuolar-type H(+)-ATPase by bafilomycin A1 augmented PELI3 protein levels, while inhibition of the proteasome had no effect. Consistently, treatment to induce autophagy by MTOR (mechanistic target of rapamycin (serine/threonine kinase)) inhibition or starvation enhanced PELI3 degradation and reduced proinflammatory Il1b expression. PELI3 was found to be ubiquitinated upon LPS stimulation and point mutation of PELI3-lysine residue 316 (Lys316Arg) attenuated Torin2-dependent degradation of PELI3. Immunofluorescence analysis revealed that PELI3 colocalized with the typical autophagy markers MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 β) and LAMP2 (lysosomal-associated membrane protein 2). Our observations suggest that autophagy causes PELI3 degradation during TLR4-signaling, thereby impairing the hyperinflammatory phase during sepsis.
Collapse
Key Words
- ACTB, actin, beta
- ATG7, autophagy-related 7
- BECN1, Beclin 1, autophagy related
- Baf A1, bafilomycin A1
- CHX, cycloheximide
- Epoxo, epoxomycin
- HBSS, Hank's balanced salt solution
- IL1B, interleukin 1, beta
- IRAKs, interleukin-1 receptor-associated kinases
- LAMP2, lysosomal-associated membrane protein 2
- LPS
- LPS, lipopolysaccharide
- MAP1LC3B, microtubule-associated protein 1 light chain 3 beta
- MAP3K14, mitogen-activated protein kinase kinase kinase 14
- MAP3K7, mitogen-activated protein kinase kinase kinase 7
- MAPK1/3, mitogen-activated protein kinase 1/3
- MAPK14, mitogen-activated protein kinase 14
- MAPK8/9, mitogen-activated protein kinase 8/9
- MTOR, mechanistic target of rapamycin (serine/threonine kinase)
- MYD88, myeloid differentiation primary response 88
- MΦ, macrophages
- NFE2L2, nuclear factor, erythroid 2-like 2
- NFKB, nuclear factor of kappa light polypeptide gene enhancer in B-cells
- NLRP3, NLR family, pyrin domain containing 3
- PELI3
- PELI3, pellino E3 ubiquitin protein ligase family member 3
- PRRs, pattern recognition receptors
- RIPK1, receptor (TNFRSF)-interacting serine-threonine kinase 1
- Rapa, rapamycin
- SQSTM1
- SQSTM1, sequestosome 1
- TABs, TGF-beta activated kinase 1/MAP3K7 binding protein 1/2/3
- TBK1, TANK-binding kinase 1
- TICAM1, toll-like receptor adaptor molecule 1
- TLRs, toll-like receptors
- TNF, tumor necrosis factor
- TRAF6, TNF receptor-associated factor 6, E3 ubiquitin protein ligase
- TUBB, tubulin, beta class I
- Torin2
- UBB, ubiquitin B
- WT, wildtype
- Wortm, wortmannin
- autophagy
Collapse
Affiliation(s)
- Annika Klara Giegerich
- a Institute of Biochemistry I-Pathobiochemistry; Goethe University Frankfurt; Faculty of Medicine ; Frankfurt , Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Haller M, Hock AK, Giampazolias E, Oberst A, Green DR, Debnath J, Ryan KM, Vousden KH, Tait SWG. Ubiquitination and proteasomal degradation of ATG12 regulates its proapoptotic activity. Autophagy 2014; 10:2269-78. [PMID: 25629932 PMCID: PMC4502749 DOI: 10.4161/15548627.2014.981914] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2014] [Revised: 07/03/2014] [Accepted: 10/01/2014] [Indexed: 11/19/2022] Open
Abstract
During macroautophagy, conjugation of ATG12 to ATG5 is essential for LC3 lipidation and autophagosome formation. Additionally, ATG12 has ATG5-independent functions in diverse processes including mitochondrial fusion and mitochondrial-dependent apoptosis. In this study, we investigated the regulation of free ATG12. In stark contrast to the stable ATG12-ATG5 conjugate, we find that free ATG12 is highly unstable and rapidly degraded in a proteasome-dependent manner. Surprisingly, ATG12, itself a ubiquitin-like protein, is directly ubiquitinated and this promotes its proteasomal degradation. As a functional consequence of its turnover, accumulation of free ATG12 contributes to proteasome inhibitor-mediated apoptosis, a finding that may be clinically important given the use of proteasome inhibitors as anticancer agents. Collectively, our results reveal a novel interconnection between autophagy, proteasome activity, and cell death mediated by the ubiquitin-like properties of ATG12.
Collapse
Key Words
- ATG, autophagy-related
- ATG12
- Act D, actinomycin D
- BCL2L1, BCL2-like 1
- BH3, BCL2 homology domain 3
- CHX, cycloheximide
- HBSS, Hank's balanced salt solution
- LC3/MAP1LC3, microtubule-associated protein 1 light chain 3
- MEF, mouse embryonic fibroblast
- RNAi, RNA interference
- UB, ubiquitin
- UBL, ubiquitin-like protein
- apoptosis
- proteasomal degradation
- ubiquitin-like protein
- ubiquitination
Collapse
Affiliation(s)
- Martina Haller
- Cancer Research UK Beatson Institute; Glasgow, UK
- Institute of Cancer Sciences; University of Glasgow; Glasgow, UK
| | | | - Evangelos Giampazolias
- Cancer Research UK Beatson Institute; Glasgow, UK
- Institute of Cancer Sciences; University of Glasgow; Glasgow, UK
| | - Andrew Oberst
- Department of Immunology; University of Washington; Seattle, WA USA
| | - Douglas R Green
- Department of Immunology; St. Jude Children's Research Hospital; Memphis, TN USA
| | - Jayanta Debnath
- Department of Pathology and Helen Diller Family Comprehensive Cancer Center; University of California, San Francisco; San Francisco, CA USA
| | - Kevin M Ryan
- Cancer Research UK Beatson Institute; Glasgow, UK
| | | | - Stephen W G Tait
- Cancer Research UK Beatson Institute; Glasgow, UK
- Institute of Cancer Sciences; University of Glasgow; Glasgow, UK
| |
Collapse
|
13
|
Maciag AE, Holland RJ, Robert Cheng YS, Rodriguez LG, Saavedra JE, Anderson LM, Keefer LK. Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance. Redox Biol 2013; 1:115-24. [PMID: 24024144 PMCID: PMC3757670 DOI: 10.1016/j.redox.2012.12.002] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2012] [Revised: 12/03/2012] [Accepted: 12/11/2012] [Indexed: 11/17/2022] Open
Abstract
JS-K is a nitric oxide (NO)-releasing prodrug of the O2-arylated diazeniumdiolate family that has demonstrated pronounced cytotoxicity and antitumor properties in a variety of cancer models both in vitro and in vivo. The current study of the metabolic actions of JS-K was undertaken to investigate mechanisms of its cytotoxicity. Consistent with model chemical reactions, the activating step in the metabolism of JS-K in the cell is the dearylation of the diazeniumdiolate by glutathione (GSH) via a nucleophilic aromatic substitution reaction. The resulting product (CEP/NO anion) spontaneously hydrolyzes, releasing two equivalents of NO. The GSH/GSSG redox couple is considered to be the major redox buffer of the cell, helping maintain a reducing environment under basal conditions. We have quantified the effects of JS-K on cellular GSH content, and show that JS-K markedly depletes GSH, due to JS-K's rapid uptake and cascading release of NO and reactive nitrogen species. The depletion of GSH results in alterations in the redox potential of the cellular environment, initiating MAPK stress signaling pathways, and inducing apoptosis. Microarray analysis confirmed signaling gene changes at the transcriptional level and revealed alteration in the expression of several genes crucial for maintenance of cellular redox homeostasis, as well as cell proliferation and survival, including MYC. Pre-treating cells with the known GSH precursor and nucleophilic reducing agent N-acetylcysteine prevented the signaling events that lead to apoptosis. These data indicate that multiplicative depletion of the reduced glutathione pool and deregulation of intracellular redox balance are important initial steps in the mechanism of JS-K's cytotoxic action.
Collapse
Key Words
- ATF, activating transcription factor
- Arylated diazeniumdiolate
- DAF-FM, 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate
- DCF-DA, 5-(and 6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate
- DMSO, dimethyl sulfoxide
- FBS, fetal bovine serum
- GSH, glutathione
- GSSG, glutathione disulfide (oxidized GSH)
- Glutathione
- HBSS, Hank's balanced salt solution
- IPA, Ingenuity Pathway Analysis
- JS-K, O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate
- LC/MS, liquid chromatography/mass spectrometry
- Leukemia
- MAPK, mitogen-activated protein kinase
- NAC, N-acetylcysteine
- NO, nitric oxide
- NSCLC, non-small cell lung cancer
- Nitric oxide
- PARP, poly (ADP-ribose) polymerase
- RNS, reactive nitrogen species
- ROS, reactive oxygen species
- SAPK/JNK, stress activated protein kinase/c-jun N-terminal kinase.
Collapse
Affiliation(s)
- Anna E Maciag
- Basic Science Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | | | | | | | | | | | | |
Collapse
|
14
|
Mobarakeh ZT, Ai J, Yazdani F, Sorkhabadi SMR, Ghanbari Z, Javidan AN, Mortazavi-Tabatabaei SA, Massumi M, Barough SE. Human endometrial stem cells as a new source for programming to neural cells. Cell Biol Int Rep (2010) 2012; 19:e00015. [PMID: 23124318 PMCID: PMC3475442 DOI: 10.1042/cbr20110009] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2011] [Accepted: 12/05/2011] [Indexed: 11/17/2022]
Abstract
Human EnSC (endometrial-derived stem cell) is an abundant and easily available source for cell replacement therapy. Many investigations have shown the potency of the cells to differentiate into several mesoderm-derived cell lineages, including osteocytes and adipocytes. Here, the potency of EnSC in neural differentiation has been investigated. Flow cytometric analysis showed that they were positive for CD90, CD105, OCT4, CD44 and negative for CD31, CD34, CD133. The characterized cells were induced into neural differentiation by bFGF (basic fibroblast growth factor), PDGF (platelet-derived growth factor) and EGF (epidermal growth factor) signalling molecules, respectively in a sequential protocol, and differentiated cells were analysed for expression of neuronal markers by RT-PCR (reverse transcription-PCR) and immunocytochemistry, including Nestin, GABA (γ-aminobutyric acid), MAP2 (microtubule-associated protein 2), β3-tub (class III β-tubulin) and NF-L (neurofilament-light) at the level of their mRNAs. The expression of MAP2, β3-tub and NF-L proteins in EnSC was confirmed 28 days PT (post-treatment) by immunocytochemistry. In conclusion, EnSC can respond to signalling molecules that are usually used as standards in neural differentiation and can programme neuronal cells, making these cells worth considering as a unique source for cell therapy in neurodegenerative disease.
Collapse
Key Words
- DAPI, 4′,6-diamidino-2-phenylindole
- DMEM, Dulbecco's modified Eagle's medium
- EGF, epidermal growth factor
- ES, embryonic stem
- EnSC, endometrial-derived stem cell
- GABA, γ-aminobutyric acid
- GFAP, glial fibrillary acidic protein
- HBSS, Hank's balanced salt solution
- MAP2, microtubule-associated protein 2
- MSC, mesenchymal stem cell
- NF-L, neurofilament-light
- PDGF, platelet-derived growth factor
- PFA, paraformaldehyde
- PT, post-treatment
- RT–PCR, reverse transcription–PCR
- T-PBS, Triton X-100 in PBS
- bFGF, basic fibroblast growth factor
- differentiation
- endometrial stem cell
- neural cell
- β3-tub, class III β-tubulin
Collapse
Affiliation(s)
- Zahra Taherian Mobarakeh
- *Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Jafar Ai
- †Department of Tissue Engineering, Faculty of Advanced Medical Technologies, Tehran University of Medical Sciences and Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran
- ‡Brain and Spinal Injury Research Center, Imam Hospital, Tehran University of Medical Sciences, Tehran, Iran
- §Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran
- ‖Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Farzad Yazdani
- *Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Zinat Ghanbari
- **Gynecology, Tehran University of Medical Sciences, Tehran, Iran
| | - Abbas Noroozi Javidan
- ‡Brain and Spinal Injury Research Center, Imam Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Mohammad Massumi
- †Department of Tissue Engineering, Faculty of Advanced Medical Technologies, Tehran University of Medical Sciences and Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | | |
Collapse
|